Market Place
Sourcing Support
EMA’s CHMP Rejects Another Drug Approved by US FDA
01 Jul 2019 //
RAPS
EMA’s CHMP Offers Negative Opinion for Sickle Cell Drug Approved by US FDA
30 May 2019 //
RAPS
EMA Sees Spike in Medicines Recommendations in 2018
05 Jan 2019 //
RAPS
Actinium Appoints Robert N. Daly, Ph.D. as VP, Head of Clinical Operations
06 Sep 2018 //
PR NEWSWIRE
J&J, Bayer fail at IInd attempt to spotlight safe benefit for Xarelto in VTE
27 Aug 2018 //
ENDPTS
Meeting highlights from the CHMP 23-26 July 2018
31 Jul 2018 //
EMA
Six medicines recommended for approval, including one orphan
24 Mar 2018 //
EMA
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
24 Mar 2018 //
RAPS
Portola Pharmaceuticals: What The Early FDA Approval Of Bevyxxa PAS Entails
21 Dec 2017 //
SEEKINGALPHA
Portola Pharma Provides Update on Bevyxxa® (betrixaban) Commercial Launch
21 Nov 2017 //
GLOBENEWSWIRE
US approval for Portola’s BevyxXa
27 Jun 2017 //
PHARMA TIMES
Fast Start for FDA Drug Approvals in 2017
13 Apr 2017 //
RAPS
FDA Informs Portola at Mid-Cycle Review for Betrixaban
08 Feb 2017 //
GLOBENEWSWIRE
IONS Scripts History, PTLA Gets FDA Date, Strongbridge Slumps, NEOT On Watch
27 Dec 2016 //
NASDAQ
Portola Pharmaceuticals Submits NDA for Anticoagulant Betrixaban
27 Oct 2016 //
DDDMAG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.